{"id":"https://openalex.org/W2169739286","doi":"https://doi.org/10.1124/mol.51.1.6","title":"D1-like Dopaminergic Activation of Phosphoinositide Hydrolysis Is Independent of D1A Dopamine Receptors: Evidence from D1A Knockout Mice","display_name":"D1-like Dopaminergic Activation of Phosphoinositide Hydrolysis Is Independent of D1A Dopamine Receptors: Evidence from D1A Knockout Mice","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W2169739286","doi":"https://doi.org/10.1124/mol.51.1.6","mag":"2169739286","pmid":"https://pubmed.ncbi.nlm.nih.gov/9016340"},"language":"en","primary_location":{"id":"doi:10.1124/mol.51.1.6","doi":"https://doi.org/10.1124/mol.51.1.6","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.51.1.6","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031247002","display_name":"Eitan Friedman","orcid":"https://orcid.org/0000-0002-6745-1733","observed_orcids":["https://orcid.org/0000-0002-6745-1733"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Eitan Friedman","raw_affiliation_strings":["Department of Pharmacology, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129, USA. friedmane@allegheny.edu","1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129, USA. friedmane@allegheny.edu","institution_ids":[]},{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066043620","display_name":"Liqing Jin","orcid":"https://orcid.org/0009-0009-9639-4836","observed_orcids":["https://orcid.org/0009-0009-9639-4836"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Li-Qing Jin","raw_affiliation_strings":["1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010584420","display_name":"Guoping Cai","orcid":"https://orcid.org/0000-0002-8725-5940","observed_orcids":["https://orcid.org/0000-0002-8725-5940"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Guo-Ping Cai","raw_affiliation_strings":["1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103341337","display_name":"Tom R. Hollon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Tom R. Hollon","raw_affiliation_strings":["1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081124038","display_name":"John Drago","orcid":"https://orcid.org/0000-0003-0335-1562","observed_orcids":["https://orcid.org/0000-0003-0335-1562"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"John Drago","raw_affiliation_strings":["1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076880355","display_name":"David R. Sibley","orcid":"https://orcid.org/0000-0002-0624-962X","observed_orcids":["https://orcid.org/0000-0002-0624-962X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"David R. Sibley","raw_affiliation_strings":["1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029990707","display_name":"Hoau-Yan Wang","orcid":"https://orcid.org/0000-0001-5005-7564","observed_orcids":["https://orcid.org/0000-0001-5005-7564"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Hoau-Yan Wang","raw_affiliation_strings":["1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Molecular Pharmacology, Departments of Pharmacology and Psychiatry, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129 (E.F., L.-Q.J., G.-P.C., H.-Y.W.), \n2Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 (T.R.H., D.R.S.), and \n3Department of Anatomy, Monash University, Clayton, Victoria, Australia (J.D.)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767","https://openalex.org/I56590836"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":2.963,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.92255902,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"51","issue":"1","first_page":"6","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9028000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9028000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.09290000051259995,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.8349999785423279},{"id":"https://openalex.org/keywords/phosphoinositide-hydrolysis","display_name":"phosphoinositide hydrolysis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/phospholipase-c","display_name":"phospholipase C","score":0.9549999833106995},{"id":"https://openalex.org/keywords/inositol-phosphates","display_name":"inositol phosphates","score":0.8119999766349792},{"id":"https://openalex.org/keywords/g-protein-coupling","display_name":"G protein coupling","score":0.7760000228881836},{"id":"https://openalex.org/keywords/g-alpha-s","display_name":"G alpha s","score":0.8270000219345093},{"id":"https://openalex.org/keywords/galphaq","display_name":"G\u03b1q","score":0.9879999756813049},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7889999747276306},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.9350000023841858},{"id":"https://openalex.org/keywords/adenylate-cyclase","display_name":"adenylate cyclase","score":0.8349999785423279},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.6359999775886536},{"id":"https://openalex.org/keywords/dopaminergic-neurotransmission","display_name":"dopamine signaling","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6202602386474609},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6136225461959839},{"id":"https://openalex.org/C2779178603","wikidata":"https://www.wikidata.org/wiki/Q356257","display_name":"Adenylyl cyclase","level":3,"score":0.5773780941963196},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.570777177810669},{"id":"https://openalex.org/C2778597717","wikidata":"https://www.wikidata.org/wiki/Q420248","display_name":"Phospholipase C","level":3,"score":0.5672964453697205},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.5460625886917114},{"id":"https://openalex.org/C2778618036","wikidata":"https://www.wikidata.org/wiki/Q2878809","display_name":"Inositol phosphate","level":4,"score":0.53341144323349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4819759726524353},{"id":"https://openalex.org/C2909816965","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine Plasma Membrane Transport Proteins","level":5,"score":0.47541433572769165},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46475353837013245},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.45078009366989136},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4454796016216278},{"id":"https://openalex.org/C120750228","wikidata":"https://www.wikidata.org/wiki/Q2035393","display_name":"Dopamine receptor D1","level":4,"score":0.4318382740020752},{"id":"https://openalex.org/C2777427919","wikidata":"https://www.wikidata.org/wiki/Q407997","display_name":"Inositol","level":3,"score":0.4196270704269409},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3986569941043854},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.305574506521225},{"id":"https://openalex.org/C2776755682","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine transporter","level":4,"score":0.20157629251480103},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006868","descriptor_name":"Hydrolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010716","descriptor_name":"Phosphatidylinositols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015647","descriptor_name":"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015647","descriptor_name":"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017447","descriptor_name":"Receptors, Dopamine D1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017447","descriptor_name":"Receptors, Dopamine D1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019204","descriptor_name":"GTP-Binding Proteins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1124/mol.51.1.6","doi":"https://doi.org/10.1124/mol.51.1.6","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.51.1.6","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:9016340","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9016340","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1215027825","display_name":null,"funder_award_id":"NS29514","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G761341830","display_name":"DOPAMINE-LINKED PHOSPHOINOSITIDE METABOLISM IN BRAIN","funder_award_id":"5r01ns029514-09","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1775749144","https://openalex.org/W1902071963","https://openalex.org/W1994518490","https://openalex.org/W2009578696","https://openalex.org/W2010299478","https://openalex.org/W2017549779","https://openalex.org/W2019213325","https://openalex.org/W2040777203","https://openalex.org/W2043001547","https://openalex.org/W2067175577","https://openalex.org/W2100837269","https://openalex.org/W2128635872","https://openalex.org/W2200434255","https://openalex.org/W2339399100","https://openalex.org/W2411570094","https://openalex.org/W2417234489","https://openalex.org/W2503231689","https://openalex.org/W6716830239"],"related_works":["https://openalex.org/W7096920598","https://openalex.org/W2009578696","https://openalex.org/W2077727405","https://openalex.org/W4400182987","https://openalex.org/W7095446080","https://openalex.org/W1984887120","https://openalex.org/W2132837863","https://openalex.org/W2029704856","https://openalex.org/W2200434255","https://openalex.org/W2030101494"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}